CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity
Julia Joung(Broad Institute), Feng Zhang(Broad Institute)
Cited by 113
Related Papers
Point-of-care testing for COVID-19 using SHERLOCK diagnostics
|medRxiv|2020|335
Prokaryotic innate immunity through pattern recognition of conserved viral proteins
|Science|2022|248
Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits
|Cell Reports|2017|242
A transcription factor atlas of directed differentiation
|Cell|2023|220
Cell type-specific delivery by modular envelope design
|Nature Communications|2023|84